Brigham Hyde

Brigham Hyde is an accomplished leader in the field of healthcare and technology, currently serving as a Venture Partner at Audere Capital LLC since June 2023 and the Chief Executive Officer and Co-Founder Board Member at Atropos Health since January 2020. Prior experience includes roles as Special Advisor and President at EVERSANA until June 2023, and as an Official Member of the Forbes Technology Council from May 2018 to August 2022. Hyde has held academic positions as a Research Affiliate at the Massachusetts Institute of Technology and as an Adjunct Professor of Pharmacology and Experimental Therapeutics at Tufts University. Additionally, Hyde has co-founded and led multiple organizations, including Concerto HealthAI, where the role of President was held, and served as CEO for Precision Health AI. Educational qualifications include a Ph.D. in Pharmacology and Experimental Therapeutics from Tufts University School of Medicine and a BS in Chemistry from Northeastern University.